Iterum Therapeutics plc (ITRM)
NASDAQ: ITRM · Real-Time Price · USD
0.4500
-0.0194 (-4.13%)
At close: Dec 12, 2025, 4:00 PM EST
0.4401
-0.0099 (-2.20%)
After-hours: Dec 12, 2025, 7:59 PM EST
Iterum Therapeutics Market Cap
Iterum Therapeutics has a market cap or net worth of $23.75 million as of December 12, 2025. Its market cap has decreased by -57.89% in one year.
Market Cap
23.75M
Enterprise Value
47.82M
1-Year Change
-57.89%
Ranking
Category
Stock Price
$0.45
Market Cap Chart
Since May 25, 2018, Iterum Therapeutics's market cap has decreased from $179.38M to $23.75M, a decrease of -86.76%. That is a compound annual growth rate of -23.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 12, 2025 | 23.75M | -51.23% |
| Dec 31, 2024 | 48.70M | 84.01% |
| Dec 29, 2023 | 26.47M | 157.57% |
| Dec 30, 2022 | 10.28M | -85.65% |
| Dec 31, 2021 | 71.61M | 47.53% |
| Dec 31, 2020 | 48.54M | -27.45% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| May 25, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 889.69B |
| Johnson & Johnson | 497.62B |
| AbbVie | 397.98B |
| UnitedHealth Group | 297.45B |
| AstraZeneca | 279.37B |
| Novartis AG | 251.91B |
| Merck & Co. | 242.30B |
| Thermo Fisher Scientific | 215.59B |